
Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.
Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.
Mario E. Lacouture, MD, discusses the psychosocial impact of dermatologic adverse events from novel therapies in melanoma.
Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer, discusses how nurses can help prevent and manage skin toxicities associated with melanoma treatment.
Published: March 18th 2015 | Updated:
Published: February 22nd 2016 | Updated:
Published: April 19th 2016 | Updated: